For many years, leading Alzheimer’s research has pointed to the accumulation of amyloid beta plaques in the brain as the cause of the disease. However, studies have resulted in inconsistent findings with regards to the buildups and their correlation to individuals exhibiting symptoms of Alzheimer’s. A recent study suggests that we might have been barking up the wrong tree for all these years.
Insulin Under Fire
The scientific community has known for some time that individuals with Type 2 Diabetes are more likely to be diagnosed with Alzheimer’s later in life. Since 2005, pathologists have suspected that insulin might be the real culprit behind the onset of the degenerative brain disorder. A lab test examined what would happen if insulin was blocked from rats’ brains.
Their neurons deteriorated, leaving the rats disoriented and confused. An analysis of their brains revealed the trademark signs of Alzheimer’s. The results of this study led one pathologist to recategorize the disease as “Type 3 Diabetes.”
A New Course Of Action
With the new possibility in mind that Alzheimer’s disease could be an insulin-related issue, treatment plans are getting a makeover. Approaching the illness from a diabetic angle could drastically improve the success rate of treatment and drop Alzheimer’s from its third-place ranking among leading causes of death in the US.
The list of contributing factors to the disease is extensive, but there are several common and easily-fixed elements: Chronic stress, poor nutrition, lack of exercise, lack of proper sleep, lack of socialization, poor mental stimulation, and high blood pressure. Genetics also play a critical role in Alzheimer’s susceptibility, but lifestyle adjustments may even be able to overcome your DNA.
Diagnosis And Treatment
To diagnose and treat the disease, potential Alzheimer’s patients undergo the Bredesen Protocol. This process involves a series of tests and evaluations to identify the underlying issues that are spearheading the cognitive decline.
After the tests, patients are given a personalized plan to help restore their brain function. These plans typically include dietary and lifestyle changes to help decrease inflammation and insulin resistance. The new approach is still awaiting proper clinical trials, but existing studies and results show much promise.